CClinicalTrials.gg
CompletedNCT01307904DatesUpdated Mar 3, 2011

The Glycemic Indices of Five Common Varieties of Dates in the Tested Among Healthy and Diabetic Subjects

An Early Phase 1 interventional study of Glucose and Dates in Diabetes Mellitus, sponsored by United Arab Emirates University. Completed at 1 site in United Arab Emirates. Open to participants aged 18 Years to 60 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2011-03-03.

Sponsored by United Arab Emirates University · Early Phase 1 and Interventional

Phase
Early Phase 1
Study type
Interventional
Enrollment
23
Allocation
Non-randomized
Ages
18 Years to 60 Years
Sex
All
01

Study summary

The main objectives of this study is to measure the composition of five common types of dates (Fara'd, Lulu, Abu ouma'n, Dabbas and Khalas) and to calculate their Glycemic Indices (GI) of these dates tested in healthy and diabetic subjects. Thirteen healthy volunteers and ten subjects with type 2 diabetes mellitus were enrolled in the study.

The dates' flesh composition analysis showed that the dates contain a high percentage of carbohydrate (total sugars, 65-68%).

The measured mean glycemic indices of the dates among healthy individuals were 54.0, 53.5, 46.3, 49.1 and 55.1 for Fara'd, Lulu, Abu Ouma'n, Dabbas and Khalas, respectively. Corresponding mean glycemic indices among individuals with type 2 diabetes were very similar 46.1, 43.8, 51.8, 50.2, and 53.0. Thus the tested five varieties of the dates are classified as low glycemic index food items.

Read the detailed description

The United Arab Emirates (UAE) has transitioned rapidly over the last 40 years. This has lead to a dramatic increase in the prevalence of obesity, metabolic syndrome, dyslipidaemia, hypertension, prediabetes and diabetes. Daily consumption of dates is the norm.The main objectives of this study is to measure the composition of five common types of dates (Fara'd, Lulu, Abu ouma'n, Dabbas and Khalas) and to calculate their Glycemic Indices (GI) of these dates tested equally in healthy and diabetic subjects. Thirteen healthy volunteers and ten subjects with type 2 diabetes mellitus were enrolled in the study. The dates' flesh composition analysis showed that the dates contain a high percentage of carbohydrate (total sugars, 65-68%).

The measured mean glycemic indices of the dates among healthy individuals were 54.0, 53.5, 46.3, 49.1 and 55.1 for Fara'd, Lulu, Abu Ouma'n, Dabbas and Khalas, respectively. Corresponding mean glycemic indices among individuals with type 2 diabetes were very similar 46.1, 43.8, 51.8, 50.2, and 53.0. Thus the tested five varieties of the dates are classified as low glycemic index food items with potential health benefits for healthy and diabetic individuals alike.

02

Conditions studied

  • Diabetes Mellitus

Browse trials for

Keywords

  • Glycemic index
  • Dates
  • Blood glucose
03

In context

Diabetes Mellitus

10,925 studies on the registry are indexed under Diabetes Mellitus; 1,319 are open to participants now.

This study's enrollment of 23 is below the median of 80 across 8,367 interventional studies indexed under Diabetes Mellitus.

Browse Diabetes Mellitus studies →

Lead sponsor

United Arab Emirates University is the lead sponsor of 24 studies on the registry; 3 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 60 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Adult
  • Healthy or having controlled type 2 diabetes mellitus

Exclusion criteria

Exclusion Criteria:

  • Morbid obesity (BMI > 40)
  • Presence of gastroenterological disorders
  • Alimentary tract surgery
  • A history of gastroenteritis in the prior six months
  • Any disease that may affect glucose metabolism
  • Alcohol intake
  • Smoking
  • Taking any medications (except metformin)
  • Poorly uncontrolled diabetes (HbA1c > 8%)
  • The presence of chronic diseases or the presence of acute illness
05

Study design

Phase
Early Phase 1
Allocation
Non-randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
23 participants (actual)

Study arms

  • Active comparator
    dates

    Each healthy and diabetic subjects received 50 grams equivalent of carbohydrates of the tested dates, On five separate days.

    Other: Dates

  • Active comparator
    sugar

    Each healthy and diabetic subjects received 50 grams of glucose

    Other: Glucose

Interventions

  • OtherGlucose

    Each healthy and Diabetic volunteers received 50 grams of glucose

  • OtherDates

    Each healthy and diabetic volunteers received 50 grams equivalent of carbohydrates of each of the five selected dates, on five separate days.

06

What researchers measure

Primary outcomes

  1. Dates Glycemic Index

    Measuring the composition of dates, selection of patients and carrying out the study

    Time frame: 4 months

07

Study locations

1 site
  • Internal Medicine Department, FMHS, UAE University
    Al Ain, Abu Dhabi, United Arab Emirates
08

References and documents

Publications

  • Alkaabi JM, Al-Dabbagh B, Ahmad S, Saadi HF, Gariballa S, Ghazali MA. Glycemic indices of five varieties of dates in healthy and diabetic subjects. Nutr J. 2011 May 28;10:59. doi: 10.1186/1475-2891-10-59. PubMed 21619670 ↗
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 3, 2011, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT01307904
Lead sponsor
United Arab Emirates University
Collaborators
Abu Dhabi Food Control Authority
First posted
Mar 3, 2011
Start date
Mar 2010
Primary completion
Mar 2010
Completion
Jul 2010
Last update
Mar 3, 2011

Study contacts

Juma M Alkaabi, MD
principal investigator · Faculty of Medicine and Health Sciences, UAE University
Bayan Al-Dabbagh, PhD
study director · Faculty of Medicine and Health Sciences, UAE University
Professor Hussein saadi, MD
study director · Faculty of Medicine and Health Sciences, UAE University
Professor Salah Gariballa, FRCP
study director · Faculty of Medicine and Health Sciences, UAE University
Ahmed Shakeel, PhD
study director · Abu Dhabi Food Control Authority
Mustafa Al Gazali, PhD
study director · Abu Dhabi Food Control Authority

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Mar 2010. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion